AUNA — Auna S.A. stock price, charts and financials

QT54Auna S.A.

Auna S.A. (NYSE: AUNA) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
5.13
-0.12-2.29%
OverviewShort InterestFilings
AUNAQT54Auna S.A.·NYSE
5.13-2.29%
TA
Loading chart...
Signal & projected range
QT Score downgradeHistorical pattern — not a prediction
Range still being built for this setupWe don’t yet have a frozen historical track record for qt score downgrade to describe a reliable spread of outcomes. The projected range appears once its backtest is established.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
VMD-15.83%$9.84AIRS+1.64%$4.96CYH+1.37%$2.96SRTA+0.36%$5.57TOI+5.56%$5.13GMRS-3.85%$12.50SNDA-4.15%$38.55TALK-1.15%$5.15
Snapshot
Index-P/E-EPS (ttm)-0.12Insider Own0.16%Shs Outstand74.02MPerf Week-1.35%
Market Cap379.74MForward P/E4.76EPS next Y1.08Insider Trans55.31%Shs Float56.15MPerf Month-3.21%
Enterprise Value1.34BPEG-EPS next Q0.02Inst Own-Short Float1.23%Perf Quarter3.64%
Income18.00MP/S0.29EPS this Y845.20%Inst Trans-Short Ratio2.28Perf Half Y6.65%
Sales1.30BP/B0.69EPS next Y20.47%ROA0.89%Short Interest688.89KPerf YTD4.27%
Book/sh7.42P/C3.09EPS next 5Y23.27%ROE4.10%52W High6.85 -25.11%Perf Year-16.86%
Cash/sh1.66P/FCF2.58EPS past 3/5Y-ROIC5.43%52W Low4.09 25.43%Perf 3Y-
Dividend Est.-EV/EBITDA5.95Sales past 3/5Y24.37% 24.45%Gross Margin37.90%Volatility3.09% 3.75%Perf 5Y-
Dividend TTM-EV/Sales1.03EPS Y/Y TTM-127.63%Oper. Margin14.09%ATR (14)0.20Perf 10Y-
Dividend Ex-Date-Quick Ratio1.00Sales Y/Y TTM11.21%Profit Margin1.51%RSI (14)51.44Recom2.50
Dividend Gr. 3/5Y-Current Ratio1.09EPS Q/Q-92.21%SMA200.20%Beta0.66Target Price7.00
Payout0.00%Debt/Eq2.05Sales Q/Q23.40%SMA503.91%Rel Volume0.53Prev Close5.25
Employees15,254LT Debt/Eq1.87EarningsAug 18SMA2000.44%Avg Volume282.42KPrice5.13
IPO DateMar 22, 2024Option/ShortYes / YesEPS/Sales Surpr.-91.63% 5.12%Net Debt/EBITDA4.31Volume149,359Change-2.29%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-06-26ReiteratedBTG Pactual$7.00
Jan-21-26ReiteratedHSBC$7.90 → $6.90
Jan-16-26InitiatedJefferiesBuy$9.00
Nov-18-25DowngradeJP MorganOverweight → Neutral
May-22-25ReiteratedHSBC$13 → $7.90
Apr-23-24ReiteratedHSBC$13
Apr-17-24InitiatedGrupo SantanderOutperform
Apr-16-24ReiteratedMorgan Stanley$14
Latest News
Company

Auna S.A. operates as a healthcare services provider, overseeing a network of hospitals and clinics across Mexico, Peru, and Colombia. The company also offers prepaid medical programs in Peru, alongside dental and vision insurance plans for clients in Mexico. This organization was established in 1989 and maintains its corporate headquarters in Luxembourg.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,3001,2331,1691,039641497413415262
Cost of Goods Sold Incl. D&A807765709654411320262253152
Gross Profit492468460385230177152161111
Selling, General and Administrative Excl. Other25825222920815313510810581
Research and Development
000000000
Other Operating Expense523832311391062
Operating Income1831771991466433345028
Interest Expense117122129144552518167
Unusual Expense
—————————
Non-Operating Income (Expense)-241-21-36-21-9-190-5
Net Income Before Taxes425649-33-12-1-43517
Income Taxes1925162485-2125
Consolidated Net Income182729-68-22-7-22211
Net Income From Continuing Operations223133-57-20-6-22211
Net Income182729-68-22-7-22211
EPS (Recurring)-0.110.860.44-1.55-0.50-0.14-0.050.510.30
EPS (Basic, Before Extraordinaries)-0.110.860.44-1.55-0.50-0.14-0.050.510.30
EPS (Diluted)-0.120.860.43-1.55-0.50-0.14-0.050.510.30
EBITDA2252412361747844316633
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio—5.7215.80——————
Price To Sales Ratio0.290.120.40——————
Gross Margin37.8537.9639.3537.0535.8835.6136.8038.8042.37
Operating Margin14.0814.3617.0214.059.986.648.2312.0510.69
Net Margin1.382.192.48-6.54-3.43-1.41-0.485.304.20
Shares Outstanding733068444548454337
Market Capitalization374148466——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$7.16$6.31$5.46$4.61$3.76● Close Price0.00K89.25K178.50K267.76K357.01KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Zamora Leon JesusPresidentMay 29 '26Buy4.156,42026,64369,130Jun 01
Wilton JohnDirectorMay 28 '26Sale4.1717,57473,30349,974Jun 01
Zamora Leon JesusPresidentMay 28 '26Buy4.179,22038,44755,134Jun 01
Zamora Leon JesusPresidentMay 26 '26Buy4.3638,727168,69345,914Jun 01
Zamora Leon JesusPresidentMay 20 '26Buy4.395,81425,52315,914Jun 01
Zamora Leon JesusPresidentMay 27 '26Buy4.2023,27397,70262,710May 28
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.